Abstract:Predicting the response of cancer patients to a particular treatment is a major goal of modern oncology and an important step toward personalized treatment. In the practical clinics, the clinicians prefer to obtain the most-suited drugs for a particular patient instead of knowing the exact values of drug sensitivity. Instead of predicting the exact value of drug response, we proposed a deep learning-based method, named Siamese Response Deep Factorization Machines (SRDFM) Network, for personalized anti-cancer drug recommendation, which directly ranks the drugs and provides the most effective drugs. A Siamese network (SN), a type of deep learning network that is composed of identical subnetworks that share the same architecture, parameters and weights, was used to measure the relative position (RP) between drugs for each cell line. Through minimizing the difference between the real RP and the predicted RP, an optimal SN model was established to provide the rank for all the candidate drugs. Specifically, the subnetwork in each side of the SN consists of a feature generation level and a predictor construction level. On the feature generation level, both drug property and gene expression, were adopted to build a concatenated feature vector, which even enables the recommendation for newly designed drugs with only chemical property known. Particularly, we developed a response unit here to generate weighted genetic feature vector to simulate the biological interaction mechanism between a specific drug and the genes. For the predictor construction level, we built this level integrating a factorization machine (FM) component with a deep neural network component. The FM can well handle the discrete chemical information and both low-order and high-order feature interactions could be sufficiently learned. Impressively, the SRDFM works well on both single-drug recommendation and synergic drug combination. Experiment result on both single-drug and synergetic drug data sets have shown the efficiency of the SRDFM. The Python implementation for the proposed SRDFM is available at at https://github.com/RanSuLab/SRDFM Contact: ran.su@tju.edu.cn, gbx@mju.edu.cn and weileyi@sdu.edu.cn.

Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response.

DeepTTA: a transformer-based model for predicting cancer drug response

An Enhanced Cascade-Based Deep Forest Model for Drug Combination Prediction

DeepCDR: a Hybrid Graph Convolutional Network for Predicting Cancer Drug Response

DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies

An Ensemble Cascade Forest‐Based Framework for Multi‐Omics Drug Response and Synergy Prediction

TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response

BCDForest: a Boosting Cascade Deep Forest Model Towards the Classification of Cancer Subtypes Based on Gene Expression Data

Cancer Classification Using Microarray Data by DPCAForest

DeepFusionCDR: Employing Multi-Omics Integration and Molecule-Specific Transformers for Enhanced Prediction of Cancer Drug Responses

MCMVDRP: a multi-channel multi-view deep learning framework for cancer drug response prediction

SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures

XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures

A Hierarchical Attention Network Integrating Multi-Scale Relationship for Drug Response Prediction

DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration

MSDRP: a Deep Learning Model Based on Multisource Data for Predicting Drug Response.

Prediction of Cancer Drug Effectiveness Based on Multi-Fusion Deep Learning Model

DeepCC: a Novel Deep Learning-Based Framework for Cancer Molecular Subtype Classification

SRDFM: Siamese Response Deep Factorization Machine to Improve Anti-Cancer Drug Recommendation

Prediction of Cancer Drug Combinations Based on Multidrug Learning and Cancer Expression Information Injection

Prediction of anti-cancer drug synergy based on cross-matching network and cancer molecular subtypes